Stylianos Karatapanis

Clinical Course of Lamivudine Monotherapy in Patients with Decompensated Cirrhosis due to HBeAg negative chronic HBV infection

Spilios Manolakopoulos, Stylianos Karatapanis, Jiannis Elefsiniotis et al. · The American Journal of Gastroenterology · 2004 · 73 citations

Medicine, Pharmacology, Pharmacotherapy +15

Nine scoring models for short‐term mortality in alcoholic hepatitis: cross‐validation in a biopsy‐proven cohort

Vasilios Papastergiou, Emmanuel Tsochatzis, Giulia Pieri et al. · Alimentary Pharmacology & Therapeutics · 2014 · 62 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Effectiveness of two quadruple, tetracycline‐ or clarithromycin‐containing, second‐line, <i>Helicobacter pylori</i> eradication therapies

Sotirios D. Georgopoulos, Spiros D. Ladas, Stylianos Karatapanis et al. · Alimentary Pharmacology & Therapeutics · 2002 · 60 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Factors that May Affect Treatment Outcome of Triple Helicobacter pylori Eradication Therapy with Omeprazole, Amoxicillin, and Clarithromycin

Sotirios D. Georgopoulos, Spiros D. Ladas, Stylianos Karatapanis et al. · Digestive Diseases and Sciences · 2000 · 50 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Nonbismuth Quadruple “Concomitant” Therapy Versus Standard Triple Therapy, Both of the Duration of 10 Days, for First-Line H. Pylori Eradication

Sotirios D. Georgopoulos, Vasilios Papastergiou, Elias Xirouchakis et al. · Journal of Clinical Gastroenterology · 2012 · 48 citations

Pharmacy, Pharmacology, Pharmacotherapy +15